This filing confirms David Zaccardelli has become a Section 16 insider (likely a new director or officer); monitor future Form 4 filings for any open-market purchases or sales that could provide signal. No immediate trading catalyst.
Price Chart
Executive Summary
David Zaccardelli filed a Form 3 initial statement of beneficial ownership with Vor Biopharma Inc. on July 9, 2026, reporting a period of July 7, 2026. The filing is an administrative requirement for a new insider—no beneficial ownership details or transaction information were disclosed in the document content. This is a routine filing with no material impact on the company's operations or valuation.
Key Facts
- Form 3 filed by David Zaccardelli as a new reporting insider of Vor Biopharma Inc.
- Report period is July 7, 2026; filed on July 9, 2026.
- No beneficial ownership amounts or share counts were provided in the filing document.
- The filing includes only a power of attorney authorizing company officers to execute future Section 16 filings.
Financial Impact
No financial impact — initial ownership statement with no disclosed holdings or transactions.
Risk Factors
- No material risks identified from this filing alone.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-299666 |
| Document: 0001193125-26-299666-index-headers.html | 0001193125-26-299666 |
| Document: 0001193125-26-299666-index.html | 0001193125-26-299666 |
| Document: 0001193125-26-299666.txt | 0001193125-26-299666 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Press Release | $23.37 $23.24 | ▼ −0.58% | ▲ +0.48% | $18.47 (−20.97%) |
Jul 9, 2026 12w ago | 3 | $19.14 $23.67 | ▲ +23.67% | ▲ +21.24% | $18.47 (−3.50%) |
Jun 11, 2026 16w ago | Institutional Cluster | $14.09 $19.75 | ▲ +40.17% | ▲ +38.28% | $18.47 (+31.09%) |
Jun 8, 2026 16w ago | Press Release | $13.29 $20.10 | ▲ +51.24% | ▲ +49.61% | $18.47 (+38.98%) |
May 7, 2026 21w ago | EFFECT | $16.08 $13.44 | ▼ −16.42% | ▼ −19.55% | $18.47 (+14.86%) |
Apr 27, 2026 22w ago | S-3 | $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $18.47 (+28.44%) |
Apr 27, 2026 22w ago | DEFA14A | $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $18.47 (+28.44%) |
Mar 27, 2026 27w ago | Press Release | $14.48 $14.12 | ▼ −2.49% | ▼ −15.23% | $18.47 (+27.56%) |
Mar 23, 2026 27w ago | Press Release | $12.15 $15.32 | ▲ +26.09% | ▲ +17.19% | $18.47 (+52.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access